214 related articles for article (PubMed ID: 25027542)
21. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation.
Chen H; Xing J; Hu X; Chen L; Lv H; Xu C; Hong D; Wu X
J Steroid Biochem Mol Biol; 2017 Jul; 171():236-246. PubMed ID: 28408351
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin promotes osteogenic differentiation of mesenchymal stem cells in rat model of osteoporosis through BMP-2/Smads signaling pathway.
Feng C; Xiao L; Yu JC; Li DY; Tang TY; Liao W; Wang ZR; Lu AQ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):434-443. PubMed ID: 31957858
[TBL] [Abstract][Full Text] [Related]
24. The role of resveratrol in bone marrow-derived mesenchymal stem cells from patients with osteoporosis.
Li J; Xin Z; Cai M
J Cell Biochem; 2019 Oct; 120(10):16634-16642. PubMed ID: 31106448
[TBL] [Abstract][Full Text] [Related]
25. Pterostilbene-isothiocyanate impedes RANK/TRAF6 interaction to inhibit osteoclastogenesis, promoting osteogenesis in vitro and alleviating glucocorticoid induced osteoporosis in rats.
Kumar V; Haldar S; Ghosh S; Chauhan S; Sharma A; Dhankhar P; Kumar A; Jaiswal S; Saini S; Gupta S; Lahiri D; Roy P
Biochem Pharmacol; 2022 Dec; 206():115284. PubMed ID: 36209841
[TBL] [Abstract][Full Text] [Related]
26. Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway.
Zeng C; Wang S; Gu H; Chen F; Wang Z; Li J; Xie Z; Feng P; Shen H; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(8):1275-1287. PubMed ID: 37365870
[TBL] [Abstract][Full Text] [Related]
27. Identification of circRNA Expression Profiles in BMSCs from Glucocorticoid-Induced Osteoporosis Model.
Chen Z; Lin W; Zhao S; Mo X; Wen Z; Cheung WH; Fu D; Chen B
Stem Cells Int; 2022; 2022():3249737. PubMed ID: 35154330
[TBL] [Abstract][Full Text] [Related]
28. MiR-291a-3p regulates the BMSCs differentiation via targeting DKK1 in dexamethasone-induced osteoporosis.
Li ZH; Hu H; Zhang XY; Liu GD; Ran B; Zhang PG; Liao MM; Wu YC
Kaohsiung J Med Sci; 2020 Jan; 36(1):35-42. PubMed ID: 31729834
[TBL] [Abstract][Full Text] [Related]
29. [Mechanisms and therapeutics of glucocorticoid-induced osteoporosis].
Kaneko K; Kawai S
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(3):138-48. PubMed ID: 21720102
[TBL] [Abstract][Full Text] [Related]
30. Uremic Serum Impairs Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stromal Cells.
Della Bella E; Pagani S; Giavaresi G; Capelli I; Comai G; Donadei C; Cappuccilli M; La Manna G; Fini M
J Cell Physiol; 2017 Aug; 232(8):2201-2209. PubMed ID: 27976811
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA telomerase RNA elements improve glucocorticoid-induced osteoporosis by EZH2 to regulate DKK1.
Hu H; Guo X; Mu T; Song H
Int J Rheum Dis; 2023 Apr; 26(4):638-647. PubMed ID: 36789537
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effect of platelet-rich plasma on glucocorticoid-induced rat bone marrow mesenchymal stem cells in vitro.
Wang Y; Luan S; Yuan Z; Lin C; Fan S; Wang S; Ma C; Wu S
BMC Musculoskelet Disord; 2022 Feb; 23(1):151. PubMed ID: 35168574
[TBL] [Abstract][Full Text] [Related]
33. [Effect of Hydroxy Safflower Yellow A on glucocorticoid-induced bone marrow mesenchymal stem cells osteogenic differentiation].
Wan T; Wu MR; Qi ZX
Zhongguo Gu Shang; 2014 Mar; 27(3):224-8. PubMed ID: 24974426
[TBL] [Abstract][Full Text] [Related]
34. The effects of α-zearalanol on the proliferation of bone-marrow-derived mesenchymal stem cells and their differentiation into osteoblasts.
Zong S; Zeng G; Fang Y; Peng J; Zou B; Gao T; Zhao J
J Bone Miner Metab; 2016 Mar; 34(2):151-60. PubMed ID: 25944420
[TBL] [Abstract][Full Text] [Related]
35. [The role of glutathione in steroid induced bone marrow mesenchymal stem cells dysfunction].
Dai Z; Zheng J; Gao Y; Liu K; Yang S; Xu W
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 Jan; 32(1):91-98. PubMed ID: 29806372
[TBL] [Abstract][Full Text] [Related]
36. [Effects of drynaria total flavonoid on osteogenic differentiation of bone marrow mesenchymal stem cells at different glucose concentrations: experiment with rats].
Shu XC; Zhu DH; Pang TJ; Sun L; Ye LH; Lu HY; Yin DC; Xie DH
Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(38):2708-12. PubMed ID: 21162903
[TBL] [Abstract][Full Text] [Related]
37. TAZ accelerates osteogenesis differentiation of mesenchymal stem cells via targeting PI3K/Akt.
Tan FZ; Dai HL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):81-88. PubMed ID: 31389578
[TBL] [Abstract][Full Text] [Related]
38. Temporal expression of Pelp1 during proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells.
Wang J; Qiang Z; Song S; Shi L; Ma C; Tan X; Yin D; Niu Z
PLoS One; 2013; 8(10):e75477. PubMed ID: 24146754
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.
Sui B; Hu C; Zhang X; Zhao P; He T; Zhou C; Qiu X; Chen N; Zhao X; Jin Y
Stem Cells Transl Med; 2016 Sep; 5(9):1238-46. PubMed ID: 27365487
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5.
Zhou J; Nie H; Liu P; Wang Z; Yao B; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):29-36. PubMed ID: 30657543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
